Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication with No FDA Approved Therapies

January 16, 2018

4 min read

Policy

Tenax Therapeutics Provides Regulatory Update On Levosimendan

July 31, 2017

2 min read

Policy

Tenax Therapeutics Meets With FDA To Discuss Positive Mortality Data And Potential Levosimendan NDA Submission

May 17, 2017

6 min read

Deals

Tenax Therapeutics CEO Steps Down, Company to Review Strategic Alternatives

April 6, 2017

5 min read

Business

Tenax Therapeutics Announces Year-End 2016 Financial Results And Provides Corporate Update

March 21, 2017

1 min read

Business

Tenax Therapeutics To Discuss Year-End 2016 Financial Results And Provide Business Update

March 16, 2017

1 min read

Drug Development

Tenax Therapeutics’s Phase 3 LEVO-CTS Trial in Cardiac Surgery Did Not Achieve Dual Endpoint

January 31, 2017

4 min read

Drug Development

Tenax Therapeutics Announces Completion Of Enrollment For Phase III LEVO-CTS Trial In Cardiac Surgery

November 18, 2016

4 min read

Business

Tenax Therapeutics Announces Third Quarter 2016 Financial Results And Provides Corporate Update

November 10, 2016

1 min read

Business

Tenax Therapeutics To Discuss Third Quarter 2016 Financial Results And Provide Business Update

November 4, 2016

1 min read

JOBS